# Revelar Biotherapeutics, Inc. — Form D

Revelar Biotherapeutics, Inc. of BETHESDA, MD, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-18. The offering totals $22.5M, of which $17.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-11-18
- Form: D
- Accession: 0001894366-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $22.5M
- Amount sold: $17.5M
- Remaining: $5.0M
- Investors: 1
- Date of first sale: 2021-11-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-421689

## Issuer

- Name: Revelar Biotherapeutics, Inc.
- CIK: 0001894366
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 9630 EAGLE RIDGE DRIVE, BETHESDA, MD, 20817
- Phone: 203-530-4466

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Paul Fonteyne | Director | New Haven, CT |
| David Scheer | Director | Foster City, CA |
| Brett Giroir | Director | College Park, GA |
| Laurence Smith | Executive Officer | New York, NY |
| Glenn Marina | Director | Bethesda, MD |
| Glenn Marina | Executive Officer | Bethesda, MD |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-02-23](https://search.stillhousedata.com/formd/0001894366-22-000001) | D | $1.0M | $1.0M |

## More

- [CIK 1894366 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1894366&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001894366-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.